New treatment options for generalized myasthenia gravis
Myasthenia gravis is an autoimmune disease in which autoantibodies against the postsynaptic membrane proteins of the neuromuscular junction disrupt impulse transmission thus causing pathological muscle weakness and fatigue that worsens throughout the day. Although the disease is not yet curable, mos...
Saved in:
Main Authors: | Antanas Vaitkus, J. Čiauškaitė, M. Malakauskaitė, M. Baublytė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2024-02-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/34581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01) -
Case report: Successful perioperative intervention with efgartigimod in a patient in myasthenic crisis
by: Shahar Shelly
Published: (2025-01-01) -
Ocular myasthenia
by: J. Zakaravičiūtė, et al.
Published: (2022-09-01) -
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01) -
Autoantibodies in myasthenia gravis: cluster analysis and clinical correlations
by: Xupeng Sun, et al.
Published: (2025-02-01)